Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2019-A00992-55 | Registry Identifier | CADETS |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In children with neurodevelopmental disorders, adolescence is usually associated with a reshaping of the clinical picture and symptomatology. Tourette syndrome (TS) is a paradigmal neurodevelopmental syndrome characterised by involuntary paroxysmal movements (motor tics) and vocalisation (vocal tics) often associated with various psychiatric disorders. The neuronal and cognitive mechanisms associated with TS symptoms improvement during adolescence, or the persistence in adulthood remains unknown, and this is what we aim to address in this study.
Thus, the aims of the present project is threefold:
Aim 1: To evaluate the maturation of cognitive functions in adolescents with TS compared to typically developing adolescents.
To achieve this aim, three distinct cognitive dimensions will be assessed in all subjects (patients and controls): (i) reward sensitivity and habit formation; (ii) cognitive impulsivity and action control and (iii) self-agency.
Aim 2: To identify neuronal correlates of cognitive function and brain development in health and disease. To achieve this aim, we will use a combined behavioural (as described in Aim 1), (i) neuroimaging and (ii) TMS approaches.
Aim 3: To predict clinical outcome . In this part of the project we aim to identify behavioural, imaging or neurophysiological markers of clinical outcome in patients with TS.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Tourette syndrome | Other | Patients with Tourette syndrome aged 13 - 18 y.o. Interventions : Brain scans, cognitive testing, TMS measures |
|
| Controls | Other | Controls matched to Tourette syndrome group nterventions : Brain scans, cognitive testing, TMS measures |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Behavioral testing on cognitive computerized tasks | Behavioral | Testing on cognitive computerized tasks |
|
| Measure | Description | Time Frame |
|---|---|---|
| Behavioral test main outcome measures [1] | reaction times | from 16 to 20 months |
| Behavioral test main outcome measures [2] | discounting factor | from 16 to 20 months |
| Behavioral test main outcome measures [3] | number of premature responses | from 16 to 20 months |
| Behavioral test main outcome measures [4] | agency composite scores | from 16 to 20 months |
| Brain MRI scan measures | whole brain structural connectivity, whole brain functional connectivity, brain cortical and subcortical structures volumes and morphology | from 16 to 20 months |
| Transcranial magnetic stimulation | Short Intracortical Inhibition (SICI) scores | from 16 to 20 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Worbe Yulia, MD, PhD | Institut National de la Santé Et de la Recherche Médicale, France | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital de la Pitié-Salpêtrière | Paris | 75013 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36460852 | Derived | Atkinson-Clement C, Duflot M, Lastennet E, Patsalides L, Wasserman E, Sartoris TM, Tarrano C, Rosso C, Burbaud P, Deniau E, Czernecki V, Roze E, Hartmann A, Worbe Y. How does Tourette syndrome impact adolescents' daily living? A text mining study. Eur Child Adolesc Psychiatry. 2023 Dec;32(12):2623-2635. doi: 10.1007/s00787-022-02116-1. Epub 2022 Dec 2. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Between group comparison
Not provided
Not provided
Not provided
Not provided
| brain MRI | Other | Brain MRI scans |
|
| TMS | Other | Measure of the cortical inhibitory capacity using TMS measures |
|